OmniBRx manufactures bioreactors and provides cell culture processing services for pharmaceutical applications.
OmniBRx provides CellBRx bioreactors for cell culture processing, used in vaccine and virus production, personalized medicine, stem and tissue culture, monoclonal antibodies, and biosimilars. Its equipment ranges from 0.5L (1 m2) to 200L (1500 m2) working volume, and it also offers validation, regulatory, repair, and training services. Founded in 2016, the company is based in Ahmedabad, India. In March 2023, it raised INR 300 million in Series A funding led by SIDBI Venture Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in